Critical Issues in Alcohol and Drugs of Abuse Testing, Second Edition, addresses the general principles and technological advances for measuring drugs and alcohol, along with the pitfalls of drugs of abuse testing. Many designer drugs, for example, are not routinely tested in drugs of abuse panels and may go undetected in a drug test. This updated edition is a must-have for clinical pathologists, toxicologists, clinicians, and medical review officers and regulators, bridging the gap between technical and clinical information. Topics of note include the monitoring of pain management drugs, bath salts, spices (synthetic marijuana), designer drugs and date rape drugs, and more.
1. Chapter 6. Introduction to Drugs of Abuse - p. 71 2. Chapter 7. Legal Aspects of Drug Testing in US Military and Civil Courts - p. 79 3. Chapter 8. Pharmacogenomics of Drugs of Abuse - p. 103 4. Chapter 9. Immunoassay Design for Screening of Drugs of Abuse - p. 121 5. Chapter 10. Issues of Interferences With Immunoassays Used for Screening of Drugs of Abuse in Urine - p. 129 6. Chapter 11. Point of Care Devices for Drugs of Abuse Testing: Limitations and Pitfalls - p. 141 7. Chapter 12. Drugs of Abuse Screening and Confirmation With Lower Cutoff Values - p. 149 8. Chapter 13. Overview of Analytical Methods in Drugs of Abuse Analysis: Gas Chromatography/Mass Spectrometry, Liquid Chromatography Combined With Tandem Mass Spectrometry and Related Methods - p. 157 9. Chapter 14. High-Resolution Mass Spectrometry: An Emerging Analytical Method for Drug Testing - p. 173 10. Chapter 15. Confirmation Methods for SAMHSA Drugs and Other Commonly Abused Drugs - p. 189 11. Chapter 16. Critical Issues When Testing for Amphetamine-Type Stimulants: Pitfalls of Immunoassay Screening and Mass Spectrometric Confirmation for Amphetamines, Methamphetamines, and Designer Amphetamines - p. 207 12. Chapter 17. Cocaine, Crack Cocaine, and Ethanol: A Deadly Mix - p. 215 13. Chapter 18. Drug-Assisted Sexual Assaults: Toxicology, Fatality, and Analytical Challenge - p. 225 14. Chapter 19. Overview of Common Designer Drugs - p. 237 15. Chapter 20. New Psychoactive Substances: An Overview - p. 247 16. Chapter 21. Review of Bath Salts on Illicit Drug Market - p. 259 17. Chapter 22. Review of Synthetic Cannabinoids on the Illicit Drug Market - p. 273 18. Chapter 23. Application of Liquid Chromatography Combined With High Resolution Mass Spectrometry for Urine Drug Testing - p. 321 19. Chapter 24. Forensic Toxicology in Death Investigation - p. 333 20. Chapter 25. Drug Testing in Pain Management - p. 343 21. Chapter 26. How Do People Try to Beat Drugs Test? Effects of Synthetic Urine, Substituted Urine, Diluted Urine, and In Vitro Urinary Adulterants on Drugs of Abuse Testing - p. 359 22. Chapter 27. When Hospital Toxicology Report Is Negative in a Suspected Overdosed Patient: Strategy of Comprehensive Drug Screen Using Liquid Chromatography Combined With Mass Spectrometry - p. 391 23. Chapter 28. Testing of Drugs of Abuse in Oral Fluid, Sweat, Hair, and Nail: Analytical, Interpretative, and Specimen Adulteration Issues - p. 405 24. Chapter 29. Advances in Meconium Analysis for Assessment of Neonatal Drug Exposure - p. 429 25. Chapter 30. Analytical True Positive Drug Tests Due to Use of Prescription and Nonprescription Medications - p. 441 26. Chapter 31. Analytical True Positive: Poppy Seed Products and Opiate Analysis - p. 449 27. Chapter 32. Miscellaneous Issues: Paper Money Contaminated With Cocaine and Other Drugs, Cocaine Containing Herbal Teas, Passive Exposure to Marijuana, Ingestion of Hemp Oil, and Occupational Exposure to Controlled Substances - p. 463 28. Chapter 33. Abuse of Magic Mushroom, Peyote Cactus, LSD, Khat, and Volatiles - p. 477 29. Chapter 34. Performance Enhancing Drugs in Sports - p. 495 30. Index - p. 511
Critical Issues in Alcohol and Drugs of Abuse Testing, Second Edition, addresses the general principles and technological advances for measuring drugs and alcohol, along with the pitfalls of drugs of abuse testing. Many designer drugs, for example, are not routinely tested in drugs of abuse panels and may go undetected in a drug test. This updated edition is a must-have for clinical pathologists, toxicologists, clinicians, and medical review officers and regulators, bridging the gap between technical and clinical information. Topics of note include the monitoring of pain management drugs, bath salts, spices (synthetic marijuana), designer drugs and date rape drugs, and more.
1. Chapter 6. Introduction to Drugs of Abuse - p. 71 2. Chapter 7. Legal Aspects of Drug Testing in US Military and Civil Courts - p. 79 3. Chapter 8. Pharmacogenomics of Drugs of Abuse - p. 103 4. Chapter 9. Immunoassay Design for Screening of Drugs of Abuse - p. 121 5. Chapter 10. Issues of Interferences With Immunoassays Used for Screening of Drugs of Abuse in Urine - p. 129 6. Chapter 11. Point of Care Devices for Drugs of Abuse Testing: Limitations and Pitfalls - p. 141 7. Chapter 12. Drugs of Abuse Screening and Confirmation With Lower Cutoff Values - p. 149 8. Chapter 13. Overview of Analytical Methods in Drugs of Abuse Analysis: Gas Chromatography/Mass Spectrometry, Liquid Chromatography Combined With Tandem Mass Spectrometry and Related Methods - p. 157 9. Chapter 14. High-Resolution Mass Spectrometry: An Emerging Analytical Method for Drug Testing - p. 173 10. Chapter 15. Confirmation Methods for SAMHSA Drugs and Other Commonly Abused Drugs - p. 189 11. Chapter 16. Critical Issues When Testing for Amphetamine-Type Stimulants: Pitfalls of Immunoassay Screening and Mass Spectrometric Confirmation for Amphetamines, Methamphetamines, and Designer Amphetamines - p. 207 12. Chapter 17. Cocaine, Crack Cocaine, and Ethanol: A Deadly Mix - p. 215 13. Chapter 18. Drug-Assisted Sexual Assaults: Toxicology, Fatality, and Analytical Challenge - p. 225 14. Chapter 19. Overview of Common Designer Drugs - p. 237 15. Chapter 20. New Psychoactive Substances: An Overview - p. 247 16. Chapter 21. Review of Bath Salts on Illicit Drug Market - p. 259 17. Chapter 22. Review of Synthetic Cannabinoids on the Illicit Drug Market - p. 273 18. Chapter 23. Application of Liquid Chromatography Combined With High Resolution Mass Spectrometry for Urine Drug Testing - p. 321 19. Chapter 24. Forensic Toxicology in Death Investigation - p. 333 20. Chapter 25. Drug Testing in Pain Management - p. 343 21. Chapter 26. How Do People Try to Beat Drugs Test? Effects of Synthetic Urine, Substituted Urine, Diluted Urine, and In Vitro Urinary Adulterants on Drugs of Abuse Testing - p. 359 22. Chapter 27. When Hospital Toxicology Report Is Negative in a Suspected Overdosed Patient: Strategy of Comprehensive Drug Screen Using Liquid Chromatography Combined With Mass Spectrometry - p. 391 23. Chapter 28. Testing of Drugs of Abuse in Oral Fluid, Sweat, Hair, and Nail: Analytical, Interpretative, and Specimen Adulteration Issues - p. 405 24. Chapter 29. Advances in Meconium Analysis for Assessment of Neonatal Drug Exposure - p. 429 25. Chapter 30. Analytical True Positive Drug Tests Due to Use of Prescription and Nonprescription Medications - p. 441 26. Chapter 31. Analytical True Positive: Poppy Seed Products and Opiate Analysis - p. 449 27. Chapter 32. Miscellaneous Issues: Paper Money Contaminated With Cocaine and Other Drugs, Cocaine Containing Herbal Teas, Passive Exposure to Marijuana, Ingestion of Hemp Oil, and Occupational Exposure to Controlled Substances - p. 463 28. Chapter 33. Abuse of Magic Mushroom, Peyote Cactus, LSD, Khat, and Volatiles - p. 477 29. Chapter 34. Performance Enhancing Drugs in Sports - p. 495 30. Index - p. 511
